IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Great Point Partners LLC

Q4 2013 Holdings

Filed 2014-02-14 | 29 holdings | $141.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Hyperion Therapeutics IncCOM44915N101$16.4K811,11311.6%
Pain Therapeutics IncCOM69562K100$13.6K2,797,6899.6%
Furiex Pharmaceuticals IncCOM36106P101$13.4K319,5369.5%
Sunshine Heart IncCOM86782U106$8.9K915,9176.3%
Ambit Biosciences CorpCOM02318X100$7.1K732,6005.0%
Ocera Therapeutics IncCOM67552A108$6.9K527,7974.8%
Infinity Pharmaceuticals Inc(INFIQ)COM45665G303$6.2K451,1004.4%
Chemocentryx, Inc(CCXIEUR)COM16383L106$5.8K1,000,0004.1%
Nanosphere IncCOM63009F105$5.7K2,500,0004.0%
Aerie Pharmaceuticals Inc.(AERIEUR)COM00771V108$5.5K308,4293.9%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$5.5K3,000,0003.9%
Veracyte Inc(VCYT)COM92337F107$5.1K353,9253.6%
Sophiris BIO IncCOM83578Q209$5.1K1,379,6603.6%
Cynosure IncCL A232577205$4.5K170,0003.2%
Alcobra LTDCOMM2239P109$4.5K250,0003.2%
Heartware Intl IncCOM422368100$4.4K46,7953.1%
Volcano CorporationCOM928645100$4.4K200,0003.1%
Protalix Biotherapeutics IncCOM74365A101$3.9K1,000,0002.7%
Horizon Pharma IncCOM44047T109$3.8K500,0002.7%
Chelsea Therapeutics Intl LTPutCOM163428105$3.2K726,8002.3%
Psivida Corp CMNCOM74440J101$2.0K500,0001.4%
Avanir Pharmaceuticals IncCallCL A NEW05348P401$1.9K567,0001.3%
MEI Pharma IncCOM NEW55279B202$1.3K157,6610.9%
Combimatrix CorporationCOM NEW20009T303$849369,0750.6%
Mast Therapeutics IncCOM576314108$5991,294,9340.4%
Streamline Health SolutionsCOM86323X106$58683,9690.4%
Rockwell MED IncCOM774374102$41840,0000.3%
Wright MED Group IncRIGHT 03/01/201998235T115$38116,6000.0%